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PREVENTION AND PREDICTION. NEW 
TECHNOLOGIES 
PREVENTION IN CLlNlCAL PRACTICE 
Lluís Salleras 
SUMMARY. The term prevention has 
been used in medicine since its very 
earliest practice to describe those activit- 
ies aimed specifically at the avoidance 
of infection and disease; as opposed to 
curative medicine which describes those 
activities which are undertaken once 
the disease has been diagnosed. 
Yet, prevention is not entirely the 
concern of medicine. Any intervention 
which reduces the probability of infec- 
t ion or disease, be it medical (e.g. 
vaccinations) or otherwise (e.g. legislative, 
environmental or social interventions) 
constitutes a preventive measure. 
Preventive medicine today includes 
practices undertaken during the presymp- 
tomatic stage, that is before the appearance 
of symptoms and clinical indications 
of disease, aimed at early detection 
(screening). This, in certain cases, provides 
a better prognosis than when the diagnosis 
is made following the onset of the disease. 
In the future, we anticipate the expansion 
of prevention to the detection of genetic 
predisposition to the disease (predictive 
medicine). 
Prevention is the main instrument of 
the new health care policy currently ap- 
plied in developed countries and which 
seeks to provide health care for everyone 
by the year 2000, with the aim of ex- 
tending life expectancy and maintaining 
the population healthy. 
At the beginning of the century, when 
the predominant pathologies were of an 
infectious nature and levels of income 
and education were low, environmental 
health care was practically non-existent. 
Consequently, improvement of health 
depended, above all, on "health protec- 
tion" measures developed by non-medi- 
cal health workers (working in environ- 
niental health and food hygiene). Today, 
in the developed countries of the west, 
where the contamination of the environ- 
ment (water, air, food) is largely under 
control and where the predominant 
health problems are chronic disease 
and accidents, the improvement of the 
population's health depends principally 
on preventive measures taken within 
the field of the "promotion of health", 
that is, preventive measures which 
apply to the individual. The most im- 
portant of which are those that health 
professionals can directly provide to 
their patients (medical advice, vaccina- 
tions, screenings, chemical prophylac- 
tics and prevention), and these will be- 
come more important in the future. 
Spitzer and Mann identify this change 
when they claim that "today the health 
of the population is increasingly in the 
hands of clinical as opposed to sanitary 
doctors", in contrast to the situation in 
the past. It is therefore apparent that the 
future of prevention depends on clinical 
preventive medicine. 
However, in Spain, until only recently 
(the seventies), preventive practices 
were by and large undertaken out-  
side the clinic: municipal vaccination 
centres, schools, factories, army and 
private medical centres. 
In the United States, France and Ger- 
many the situation was not unsimilar. In 
the twenties the American Medical As- 
sociation and the Metropolitan Life In- 
surance Company recommended an- 
nual medical check ups (thorough 
periodic examinations or systematic 
medical examinations) for al1 adults, as 
they were considered beneficia1 for 
long-term health. Until very recently, 
systematic annual medical examina- 
tions were considered, along with vac- 
cinations, as being paradigmatic of 
preventive medic ine in  wor ldw ide  
medical practice. In the United States 
health care organizations offering their 
clients thorough annual examinations, 
on payment of a modest annual fee, 
proliferated. In France and Germany, 
with a non-integrated health care system, 
the Social Security budget financed the 
establishment of preventive medicine 
centres with the aim of offering periodic 
medical examinations to those thus 
insured. 
As we entered the seventies, the 
growing cost of these examinations, 
the changing expectations of patients and 
the introduction of precise techniques 
for the study of the efficiency and effec- 
tiveness of these screenings cast doubt 
on the value of annual medical examin- 
ations. The clinics began to express 
their concern and, as a consequence of 
expert research and recommendations 
from scientific organisations, in the last 
few years these clinics have been grad- 
ually abandoned in the United States 
and in most developed countries to be 
replaced by "programmed preventive 
measures", planned over time and con- 
sisting of a pack of preestablished meas- 
ures, in accordance with the prevalent 
health problems in the community and 
according to the age and sex of the pat- 
ient. Such packs include several of the 
classic screenings offered in periodic 
examinations, but in addition primary 
preventive measures (vaccinations, 
health education). 
N E W  RISK MARKERS 
Miquel Rutilant 
SUMMARY. The development of 
clinical epidemiology and of molecu- 
lar genetic technology might provide 
the tools for a more effective preventive 
medicine and, even, furnish new mar- 
kers which would enable us to practise 
preventive medicine on an individual 
scale. 
In order to establish the feasibility of 
this, their usefulness is analysed in mon- 
ogenic and polygenic diseases. In the 
latter case, the model of hereditary 
breast-ovary cancer is used. 
For hereditary monogenic diseases it 
is possible, either directly or indirectly, to 
detect: 1 )  female carriers of a recessive 
defect bound to the X chromosome; 2) 
carriers of recessive autosomic diseases; 
3) carriers or subjects in the presympto- 
matic stage of dominant autosomic dis- 
eases, and 4) a prenatal or preimplanta- 
tional diagnosis of around 200 diseases, 
the genes of which have been identified 
and localised. 
Unlike individual prediction, which 
in the case of monogenic hereditary dis- 
eases has a reliability around 100°/o, in 
the case of cancer and other polygenic 
diseases, particularly of a hereditary nat- 
ure, the level of prediction is still far 
from reliable. Even in such well-resear- 
ched cases as hereditary breast-ovary 
cancer, for which new markers have 
been defined -BRCA-1, BRCA-2, p-53, 
telangiectasis ataxia gene. etc.- it is still 
not possible to make individual predic- 
tions with sufficient reliability, though it 
wil l be possible in the short term. 
THE PREDlCTlON OF CERVICAL CANCER 
Francesc Xavier Bosch 
SUMMARY. The risk prediction of 
cervical cancer is based on the identifi- 
cation of preinvasive lesions detected 
cytologically. The preventive measure 
consists of the recommended repetition 
of cytological smears at frequent inter- 
vals. One of the unnecessary costs of 
this policy is that not al1 the lesions det- 
ected are likely to develop the invasive 
cancer, and that a large number (around 
8O0/0) of routine cytological smears are 
normal. 
Over the last decade an infectious 
agent, the virus of the human papilloma, 
has been identified as being responsible 
for practically al1 cases of cervical can- 
cer. This has been accomplished using 
DNA cell analysis techniques aimed at 
identifying sequences of DNA viruses. 
These techniques are now highly 
standardised, reliable and easily repro- 
ducible. 
The risk marker is therefore present 
for an indeterminate time before the 
appearance of abnormal cytological 
smears. Moreover, the epidemiology of 
this infection, a disease which is funda- 
mentally of a sexually transmitted nat- 
ure, indicates that the risk is linked to 
the number of sexual partners, and that 
the risk decreases with age. 
It would seem that a woman who has 
not been infected by the papilloma vi- 
rus by a certain age, and who is not par- 
ticularly sexually promiscuous, is at a 
very low risk of contracting cervical 
cancer. Therefore, theoretically, preven- 
tion based on cytological screening 
would no longer be necessary. 
The social and economic implica- 
tions of these findings are considerable. 
PREVENTION AND PREDICTION. NEW 
TECHNOLOGIES: SUMMARY AND CONCLUSIONS 
Josep Laporte 
Public health policies in Catalonia 
lay great emphasis on the prevention of 
illness as a key element in increasing 
quality of life. 
Progress in our understanding of the 
human genome has enabled us to begin 
to apply preventive medicine to mono- 
genic, hereditary diseases. Priority must 
be given to the early diagnosis of part- 
icular types of cancer; at the same time, 
certain types of mass screening which 
offer no special advantages can be dis- 
carded. 
Risk markers have clear predictive 
and preventive significance, although 
the anxiety that certain tests may arouse 
in patients is a factor that should be 
taken into consideration. 
